Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today's conference call may be recorded.
Cellectar Biosciences Inc. (CLRB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.88 | 8,680 | $24,998.40 | 20,451 | 2026-05-07 | Filing | |
| $2.88 | 8,680 | $24,998.40 | 20,318 | 2026-05-07 | Filing | |
| $4.99 | 10,000 | $49,900.00 | 11,638 | 2025-07-02 | Filing | |
| $4.99 | 10,000 | $49,900.00 | 12,768 | 2025-07-02 | Filing | |
| $4.99 | 5,000 | $24,950.00 | 6,418 | 2025-07-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.70 | 198 | $731.99 | 10 | 2025-12-12 | Filing | |
| $2.21 | 53 | $117.13 | 0 | 2018-11-29 | Filing | |
| $2.21 | 939 | $2,075.28 | 53 | 2018-11-29 | Filing | |
| $1.18 | 13,000 | $15,397.20 | 67,000 | 2018-03-13 | Filing | |
| $1.20 | 34,000 | $40,704.80 | 213,548 | 2018-03-12 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 21,850 | $60,743 | 0% |
News See All
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome. At this time, all participants are in listen-only mode. Following the presentation, there will be a question-and-answer session.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q3 2025 Earnings Call Transcript
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q3 2025 Earnings Call Transcript November 13, 2025Cellectar Biosciences, Inc. beats earnings expectations.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today's conference is being recorded.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome. At this time all participants are in listen-only mode. Following the presentation, there will be a question-and-answer session.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome. At this time all participants are in listen-only mode. Following the presentation, there will be a question-and-answer session.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q3 2024 Earnings Call Transcript
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q3 2024 Earnings Call Transcript November 18, 2024Cellectar Biosciences, Inc. misses on earnings expectations.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Cellectar Biosciences Second Quarter 2024 Financial Results Call. Today’s call is being recorded.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q1 2024 Earnings Call Transcript
Operator: Good morning and welcome to Cellectar Biosciences First Quarter 2024 Earnings Call. Today's call is being recorded.
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript
Operator: Good morning. And welcome to Cellectar Biosciences 2023 Yearend Earnings Call. Today's call is being recorded.
Hedge Fund Resource Center